Events & Presentations

Upcoming Event

Date Event Details Remind Me
Summary Toggle Tuesday, May 08, 2018 4:30 PM EDT

Five Prime Therapeutics, Inc. 2018 Q1 Quarterly Earnings Call

Presentations

Title Documents

January Corporate Overview

Pipeline

Archived Events

Date Event Details
Summary Toggle Monday, March 12, 2018 11:20 AM EDT

Cowen and Company 38th Annual Health Care Conference

Supporting Materials

Summary Toggle Tuesday, February 27, 2018 4:30 PM EST

Five Prime Therapeutics, Inc. 2017 Q4 Quarterly Earnings Call

Supporting Materials

Summary Toggle Wednesday, February 14, 2018 11:30 AM EST

LEERINK Partners 7th Annual Global Healthcare Conference

Supporting Materials

Summary Toggle Tuesday, January 09, 2018 4:30 PM PST

36th Annual J.P. Morgan Healthcare Conference

Supporting Materials

Summary Toggle Tuesday, January 09, 2018 4:30 PM PST

36th Annual J.P. Morgan Healthcare Conference

Speaker

Aron Knickerbocker
Senior Vice President and Chief Business Officer
Summary Toggle Thursday, December 14, 2017 11:30 AM EST

BMO Capital Markets Prescriptions for Success Healthcare Conference

Summary Toggle Saturday, November 11, 2017 5:45 PM EST

Five Prime Therapeutics Conference Call

Supporting Materials

Summary Toggle Wednesday, November 08, 2017 8:00 AM EST

Five Prime Therapeutics Conference Call

Supporting Materials

Summary Toggle Monday, November 06, 2017 4:30 PM EST

Five Prime Therapeutics, Inc. 2017 Q3 Quarterly Earnings Call

Supporting Materials

Summary Toggle Thursday, September 28, 2017 9:00 AM EDT

LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology

Supporting Materials

Summary Toggle Tuesday, August 08, 2017 4:30 PM EDT

Five Prime Therapeutics, Inc. 2017 Q2 Quarterly Earnings Call

Supporting Materials

Summary Toggle Wednesday, June 07, 2017 11:00 AM EDT

Jefferies 2017 Global Healthcare Conference

Supporting Materials

Summary Toggle Thursday, May 04, 2017 4:30 PM EDT

Five Prime Therapeutics, Inc. 2017 Q1 Quarterly Earnings Call

Supporting Materials

Summary Toggle Monday, September 19, 2016

Five Prime Therapeutics Rings the NASDAQ Stock Market Opening Bell

Five Prime Therapeutics (Nasdaq: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, will visit the Nasdaq MarketSite in Times Square.

In honor of the occasion, Lewis T. “Rusty” Williams, Founder, President and CEO, will ring the Opening Bell. 

Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to improve the lives of patients with serious diseases. Five Prime's comprehensive discovery platform, which encompasses virtually every medically relevant extracellular protein, positions it to explore pathways in cancer, inflammation and their intersection in immuno-oncology, an area with significant therapeutic potential and a growing focus of the company's R&D activities. Five Prime has entered into strategic collaborations with leading global pharmaceutical companies and has promising product candidates in clinical and preclinical development. For more information, please visit www.fiveprime.com.

Summary Toggle Tuesday, May 05, 2015 8:30 AM EDT

Five Prime Therapeutics 2015 R&D Day

Supporting Materials